Clostridium difJicile is a human pathogen that produces two types of toxins, A and B, that cause a potentially lethal gastrointestinal syndrome termed pseudomembranous colitis. Virtually nothing is known about the mechanism of regulation of toxin production in this organism, and cis-regulatory regions of neither toxin have yet been identified, thus prompting this investigation. A motif homologous with the ShineDalgarno sequence of Escherichia coli occurs upstream from the putative initiation codon of toxin B, making this region also a candidate to contain a promoter. Therefore, a subgenomic DNA library of C. dijj'jcile in a plasmid vector was first constructed encompassing the 5'-end of the toxin B gene. A 450-bp DNA fragment was excised from the subgenomic DNA library clone and subcloned into a promoter-probe plasmid vector that contains two divergently oriented, promoterless genes to assay for promoter function. This subcloned DNA fragment directed the expression of alkaline phosphatase, a reporter gene product of the promoterless vector, thus indicating the presence of a functional promoter. To locate the promoter more precisely, a series of nested deletions of the toxin B promoter subclone was constructed with exonuclease 111. The promoter that facilitates expression of the toxin B gene in E. coli was localised, based on alkaline phosphatase activity. The transcriptional initiation site of toxin B mRNA in E. coli was mapped by primer extension analysis, suggesting two closely associated tandem start sites directed by two similarly spaced promoters within this localised region.
Introduction
Clostridium dztjcicile is a gram-positive, spore-forming, anaerobic bacillus. It is the aetiological agent of pseudomembranous colitis (PMC) in man, a severe, potentially lethal gastrointestinal disease that is characterised by a range of clinical presentation from a self-limited diarrhoea to an acute and fulminant colitis [l-31. The development of the disease is a serious side-effect of treatment of patients with various antimicrobial agents. It is thought that C. dzflcile causes disease by producing two exotoxins, designated toxins A and B [4-71. Toxin A is a potent enterotoxin that produces extensive tissue damage in the gut mucosa of tested animals. In addition to its enterotoxic activity, toxin A is also cytotoxic. Toxin B is a potent cytotoxin, although it does not cause a significant response when given intragastrically to hamsters. However, it becomes lethal in combination with low doses of toxin A. This suggests that toxin A initiates tissue damage that provides toxin B with access to sensitive tissues. Both toxins are very high mol. wt proteins, and both appear to be produced in most toxigenic strains of C. difJiciZe.
C. difJiciEe strains can vary significantly in how much of both toxins they produce, but a 1:l ratio is maintained by most strains, suggesting co-ordinated regulation [8, 91 . Although the genes for both toxins have been cloned and sequenced [lo-121, thus far, the underlying molecular mechanism(s) that yield a balanced expression of both C. dztjcicile toxin genes have not been elucidated. This is principally due to the inability to transform C. dztjcicile. However, previous experiments by Dailey and Schloemer [ 131 and Barroso et al. [ 101 suggest that Escherichia coli may be a useful alternative organism to test for promoter activity of C. dzJiciZe genes.
A candidate promoter for the toxin B gene is located between the presumed initiation codon of toxin B and the upstream %a1 site. DNA sequence analysis of this upstream region reveals a potential ShineDalgarno ribosome-binding site, AGGAG, 8-bp 5' to the putative initiation codon of toxin B gene. It is highly homologous to both the consensus sequence of E. coli, as well as those of clostridial strains, as summarised by Young et al. [14] . This prompted the current study on the identification and characterisation of a promoter for toxin B. The study showed that this DNA sequence has promoter activity in E. coli. The transcriptional start site of toxin B mRNA was also characterised, suggesting a location for the promoter site.
Materials and methods

Bacterial strains, media and plasmids
A highly toxigenic strain of C. dificile (strain VPI 10463) was obtained from Virginia Polytechnic Institute and State University in Blacksburg, VA, USA. The strain was grown anaerobically in Brain-Heart Infusion Broth (Difco Laboratories, Detroit, MI, USA). The E. coli strains used were DH5aF'IQ ($80 dlacZAM15, A(lacZYA-argF)U169, recA1, endAl, hsdRl7 (rK-, mK+), supE44, A-, thi-1, gyrA, relA1, [F', proABS, laclqZAM15, zzf::Tn5(Kmr]]) and CCll8 (araD139, A(ara, leu)7697, AlacX74, phoAA20, galE, galK, thi, rpsE, rpoB, argE(am), recA1). SOB medium (500 ml of water with tryptone 10 g, yeast extract 2.5 g NaCl 0.292g and KCl 0.093 g) and WB buffer (glycerol 10% and distilled water 90%) were used for the electroporation procedure. The pQF 1 1 0 plasmid vector, which contains a pair of divergently oriented, promoterless reporter genes (the alkaline phosphatase gene, phoA, and the luciferase gene, lux, one on each side of the multiple cloning region), was obtained from Dr Kropinsky [15] and was used as a promoter-probe vector. The plasmid pIBI25 (International Biotechnologies, New Haven, CT, USA) was used both in the construction of the subgenomic DNA library and as a cloning vehicle.
Molecular cloning, enzymes and DNA manipulations
The E. coli strain, DHSaF'IQ, was used in the construction of a subgenomic DNA library, and CC118 was used in the alkaline phosphatase assay. Both were transformed with plasmid DNA and grown aerobically on LB agar plates or in LB broth [16] supplemented with ampicillin 40 mg/L when appropriate. Isolation of plasmid DNA from E. coli was performed by a modified boiling lysis method [17] . Bacterial genomic DNA was obtained from C. dzficile grown to log phase. Restriction endonucleases, T4 polynucleotide kinase, T4 DNA ligase and Klenow fragments were purchased from Boehringer Mannheim (Indianapolis, IN, USA), New England BioLabs (Beverly, MA, USA) and Promega Corporation (Madison, WI, USA) and they were used in accordance with the manufacturers' directions. 5-Bromo-4-chloro-3-indolyl phosphate (X-P) was from United States Biochemical (Cleveland, OH, USA). The exonuclease I11 assay was done with the Erase-a-Base System (Promega Corporation). SuperscriptTM RNAase Hreverse transcriptase (BRL Life Technologies, Gaithersburg, MD, USA) was used in the primer extension assay. Unless otherwise stated, molecular techniques were used as described earlier [ 181.
Synthetic oligonucleotides
Synthetic oligonucleotides used for Southern blotting, DNA sequencing and primer extension analysis were either synthesised on a BioSearch 8700 DNA synthesiser (MilliGen/BioSearch, San Rafael, CA, USA) by the phosphoramidate method and purified by preparative polyacrylamide gel electrophoresis, or purchased from Integrated DNA Technologies (Coralville, IA, USA). The oligonucleotide primers used were as fol- 
Electroporation
The electroporation of E. coli cells was done with the Cell-PoratorTM Electroporation System and CellPoratorTM Voltage Booster from BRL Life Technologies, according to their recommendations. The electrocompetent cells were prepared by growing 500ml of cells in SOB medium with vigorous aeration at 37°C until an OD550 of 0.8 was reached. The cells were then washed and resuspended in 500 ml of ice-cold sterile WB buffer twice. The cells were made competent by resuspension in 2 ml of WB buffer. Plasmid DNA was then mixed with 20 pl of electro-competent cells and suspended in the 0.15-cm electrode gap MicroElectroporation Chamber. The electroporation procedure was carried out with the pulse setting of 330-pF capacitance, 4 kQ resistance and 2.4 kV voltage, producing a time constant of c. 6 ms.
DNA sequencing
The DNA sequence was determined by the dideoxychain termination method of Sanger et al. [19] with labelled oligonucleotide primer, SEQ. The thermal cycle sequencing reactions were performed in a Coy 50 Tempcycler (Coy Laboratory Products, Grass Lake, MI, USA) with thermostable VentR@(exo-) DNA polymerase (New England BioLabs). Sequencing reactions were done on denaturing polyacrylamide 5% gels
Construction of a C. d@cile subgenomic DNA libra y
The toxin B subgenomic DNA library of C. difJile was constructed by digesting C. dificile genomic DNA with EcoRV to completion. The digest containing the fragment of interest was separated by sucrose gradient centrifugation and the proper fraction identified by Southern blot analysis with an oligonucleotide probe, TOXB, which recognises the 5'-end of toxin B. This fraction was cloned in a pIBI25 plasmid vector prepared by EcoRV digestion (Fig. 1 ) and transformed into bacterial strain DHSaF'IQ by electroporation. The colonies obtained were screened by the GrunsteinHogness hybridisation technique [20] with the same oligonucleotide probe.
Cloning of a DNA fragment containing a putative promoter element
Clone B ( Fig. 1 ) was digested with RsaI, separated by agarose gel electrophoresis, and a 2.2-kb DNA fragment was electro-eluted, ligated to a Sma I-digested pIBI25 plasmid vector, and the product was transformed into E. coli strain DH5aF'IQ. The resultant clone, pRStoxB (Fig. l) , was then digested with XbaI to release a fragment of 460bp. This DNA fragment was subcloned into the XbaI site upstream of a promoterless alkaline phosphatase gene of E. coli vector pQF 1 10 [ 151. The resultant recombinant clone, pPB ( Fig. l) , was transformed into an alkaline phosphatase-deficient bacterial host, CC118, and examined for alkaline phosphatase activity. The portion of the toxin B structural gene in the 460-bp insert DNA was in the same polarity as the alkaline phosphatase gene in pQFl10 vector (Fig. 1) . The junctional regions of the clones were confirmed by DNA sequencing.
A lkalin e p h osp h a tase assays
The alkaline phosphatase activities were assayed by both screening qualitatively for blue bacterial colonies grown overnight at 37°C on LB plates with X-P 40 pg/ml, and quantitatively by measuring spectrophotometrically the rate of p-nitrophenyl phosphate hydrolysis at OD420 by permeabilised cells according to Manoil and Beckwith [21] .
Construction of nested deletions of the promoter
The pPB promoter clone DNA was prepared by digesting with both KpnI and BamHI enzymes and then exonuclease I11 at 20°C from 0.5 min to 8 min at 30-s intervals, followed by S1 digestion, Klenow treatment, ligation and transformation into CC 1 18 bacterial host. The Sl nuclease digestion was done at 4°C and with 500 mM NaCl to more rigorously control the digestion. The progressive deletion of pPB clone was initiated fkom the BamHI site towards the putative promoter region of toxin B. Colonies were selected for each time point, and the plasmid DNA was prepared for further restriction enzyme characterisation by both BssHII and HindIII, and analysed on a high resolution agarose 1.5% gel. The authenticity of each deletion clone was verified by DNA sequencing.
Isolation of RNA
Whole-cell RNA was extracted from cultures of E. coli as described by Reddy and Gilman [22] with slight modifications. Briefly, a 100-ml culture of E. coEi was grown to an optical density of 0.8 at 550 nm. The cells were then resuspended in STET lysing buffer (sucrose 8%, Triton X-100 5%, 50 mM EDTA, 50 mM Tris HCl, pH 7.0), and extensively vortex mixed in phenol/ chloroform reagent. The nucleic acid was precipitated with ethanol, and dissolved in diethyl pyrocarbonate (DEPC)-treated water. The phenol/chlorofom extraction was repeated twice and the final nucleic acid pellet was dissolved in 9 ml of DEPC-treated water containing 4.5 g of CsCl, layered over a 3-ml cushion of 5.7 M CsCl, and centrifuged at 30 000 rpm for 24 h at 20 "C in a Beckman SW41 rotor. The supernate was discarded after centrifugation and the RNA pellet was dissolved in DEPC-treated water, and precipitated with ethanol again. Purified RNA was dissolved in 200 pl of DEPC-treated water, and its concentration was determined by absorbance at 260 nm.
Primer extension of mRNA
Primer extension was performed on whole-cell RNA extracted as above by a modified procedure of Triezenberg [23] . The annealing of the radiolabelled primer, PriExt, to the RNA was done at 80°C for 3 min, followed by cooling of the sample to 37°C for a further 30 min. The primer extension reaction was performed at 42°C for 1 h without actinomycin D, and the product was analysed on a polyacrylamide 9% gel.
Results
Ident8cation of a promoter region in clone pPB
Clone B (Fig. 1) from the subgenomic DNA library contained an 8.8-kb EcoRV-digested DNA fragment, which included 3.8 kb of the 5'-end of the toxin B gene that was previously sequenced [lo], and another uncharacterised 5 kb of DNA upstream from the toxin B gene. The DNA of clone B was assayed for promoter activity with the promoterless plasmid vector, pQFl10 [15] . The resultant recombinant clone, pPB (Fig. l) , contained 400 bp of DNA sequence upstream from the initiation codon of toxin B. When this clone was tested on LB plates with X-P, it displayed a blue colour phenotype. The parental plasmid, pQF 1 10, produced only white colonies, indicating that the blue recombinant clones exhbited a promoter activity resulting from the cloned insert. Quantitative analysis (Table 1) promoter activity in clone pPB with p-nitrophenyl phosphate showed significant alkaline phosphatase activity compared to the parental clone, pQFl10, thus confirming the earlier results from the X-P phenotypic analysis that the cloned DNA fragment indeed contained promoter activity. 
Localisation of the promoter region by nested deletion analysis
To localise the position of the putative promoter in clone pPB, a set of nested deletions of the clone was performed with an exonuclease I11 assay. Six of the clones shown (Fig. 2) , represented deletions from 79 bp to 232 bp, and they were analysed for functional promoter activity. The results of the alkaline phosphatase phenotype characterisation of these deletion clones are also shown in Fig. 2 , where deletion clones pPB27, pPB71 and pPB83 conferred a white colony phenotype, and three others, pPB16, pPB17 and pPB18, conferred a blue phenotype. The alkaline phosphatase activity of the promoterless vector disappeared with a transition from deletion clone pPB18 to pPB27, implying that essential promoter fbnction exists within this deleted region. A quantitative assay with p-nitrophenyl phosphate showed that clones pPB16, pPB17 and pPB18 exhibited much higher alkaline phosphatase activity than the other three clones, pPB27, pPB71 and pPB83. These results were consistent with the phenotypic analysis of the nested deletion clones with X-P (Fig. 2) .
Primer extension analysis to localise the start site of toxin B transcript
The transcriptional initiation site of the toxin B mRNA was identified by primer extension analysis with the 5'-end-labelled primer, PriExt, and total RNA extracted from clone pPB. Two product bands were observed (Fig. 3) , indicating that the 5'-end of the toxin B mRNA was produced by two different promoters. Control experiments with either the RNA extracted from cells carrying the parental pQFl10 vector, or adding RNAase prior to primer extension analysis did not show any product (Fig. 3) . Therefore, the primer extension initiated from the mRNA encoded by the cloned DNA fragment. The longer transcript was mapped to an adenine residue which was 15 bp upstream of the presumed toxin B start codon [lo] (Fig. 4) , and the shorter transcript started at a guanine residue 9 bp upstream of the toxin B start codon [lo], which was also the last base of the 3'-end of the putative Shine-Dalgarno sequence (Fig. 4) .
Discussion
This study aimed to determine the location of the promoter for the toxin B gene of C. dificile, a clinically relevant organism whose toxins are believed to be the principal virulence factors in the enteric disease, pseudomembranous colitis. The study is necessarily done with E. coli, as C. dzficile has not yet been successfully transformed with exogenous DNA. Based on the analysis of clone pPB (Fig. l) , promoter activity was found within the 400-bp DNA fragment upstream from the putative start codon of the toxin B gene. However, it is noted that the authentic initiation codon of the toxin B gene is not yet known, whether it is expressed in E. coli or C. dificile. Subsequent deletions of clone pPB, followed by sequence analyses, also showed that if > 38 bp upstream of the presumed toxin B gene initiation codon are deleted, promoter activity would be lost, yet it would not be affected if only 11 bp of DNA are deleted (Fig. 2) . This indicates that an essential part of the promoter occurs within the 1 1 -38-bp region upstream of the presumed start codon of the toxin B gene.
Also, as noted in Table 1 , clone pPB exhibits 4.2-9.4-fold less promoter activity than three of the deletion clones (pPB16, pPB17 and pPB18), as measured by the p-nitrophenyl phosphate assay. A possible explanation for this phenomenon is the presence of an inhibitory factor acting either at the transcriptional or translational levels to reduce the amount of the alkaline phosphatase activity being synthesised. It is not known why the alkaline phosphatase activity of clone pPB16 is lower than that of clones pPB17 and pPB18, although this is a very reproducible phenomenon. We speculate that this may be related to a less optimal positioning of the Shine-Dalgarno sequence in clone pPB16 compared to these other two clones, thus possibly reducing the efficiency of translation of the alkaline phosphatase product of clone pPB 16. Never- RNA isolated from clone pPB was reverse transcribed into cDNA (*) with an 18-bp 5'-end-labelled oligonucleotide probe, and analysed on a denaturing polyacrylamide 5% gel. The sequence ladder (labeled A, C , G , T) shown is the antisense strand of DNA which was generated from the cloned DNA, using the same labelled oligonucleotide that was used for primer extension. The sequence around both transcriptional initiation sites is shown on the right. The 5'-ends of the two transcripts begin at P1 and P2. The originally assumed initiation codon [lo], ATG, is also shown.
theless, these results still suggest that an essential part of a promoter is contained within the 27-bp DNA sequence missing in clone pPB27, as compared to clone pPB18 (Fig. 2) , It has recently been reported [24] that a small opening reading frame immediately upstream of the toxin B gene encodes a positive regulator for production of toxins A and B. This "-45" "-35"
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protein might be expected to collaborate in vivo with the RNA polymerase of C. dzficile to up-regulate production of both toxins, e.g., as a transcriptional activator or an alternative sigma factor.
The transcript mapping experiment (Fig. 3) showed two major bands of transcriptional initiation for the toxin B gene, when examining total RNA from clone pPB. Moreover, these two transcriptional initiation sites map in a location consistent with the promoter localisation results above. Taken together, these results suggest a two promoter model for transcriptional initiation of the toxin B gene, when it is expressed in this context in E. coli. Based on this model, the locations of both sets of -35 and -10 regions of the toxin B promoter can be inferred, assuming that these promoters share significant homology with the E. coli cr70 consensus sequence [25] . In fact, two sets of promoter sequences, P1 and P2, can be postulated that are not only consistent with both transcripts, but are also closely related to promoter consensus sequences of gram-positive organisms [26] in general, and C. perfingens [27] in particular (Fig. 5) . No comparable data are yet available for any genes of C. dzficile. The P 1 sequence, TATAAA(N)20TAAAAA, is proposed to constitute the -35 and -10 elements of the longer transcript, and the P2 sequence, TTAGCA(N)17 TATAGT, is proposed for the promoter elements of the shorter transcripts (Fig. 6 ).
It is noteworthy that each transcript would begin only a few bases away from the proposed start codon of the toxin B gene [lo] (Fig. 6 ). In fact, the longer transcripts starts only 2 bp away from the putative Shine-Dalgarno sequence, and the start of the shorter transcript is even embedded within the same sequence (Fig. 6) . Consequently, it is doubtful that toxin B mRNA would be translated from its presumed initiation site [lo] . However, another potential inframe ATG initiation sequence is located 30 bp downstream from the putative start codon of the toxin B gene [lo] (Fig. 6 ). This alternative putative initiation sequence is preceded by the sequence, 5'-AGAAA-3', which, although not a strong E. coli Shine-Dalgarno sequence, does exhibit perfect complementarity to the 3'-terminus of the C. perfringens 16s rRNA, 3'-UCUUUCCUCCACUAG-5' [28] , and consequently is likely to be fimctional in C. dzficile. , [26] ), C. perfringens (C. perf., [27] ) and E. coli [25] are shown. The '-45' region is the postulated conserved sequence for gram-positive bacteria [26] . The proposed promoter sequences for both the longer and shorter transcripts are listed as PI and P2, respectively. Spaces in the sequence correspond to alignment gaps. However, it remains to be determined which initiation codon is used in vivo by C. dzficile.
These two proposed promoters for toxin B not only fit the current models of E. coli and gram-positive [26, 271 consensus promoter sequences, but they also find additional support from gram-positive organisms in the -45 region of the promoter (Fig. 5) . Further support for this model comes from clone pPB27 (Fig.  6 ), which does not contain both proposed -10 regions of this double promoter, and therefore would not be expected to express the alkaline phosphatase gene, as is actually observed (Fig. 2) . In addition, other deletion clones, which either contain all the essential promoter elements known for E. coli, or none, display an alkaline phosphatase activity (Fig. 2 ) consistent with this double promoter model (Fig. 6 ).
If both promoters are used in vivo for C. dzflcile, a
